tribulosin

from Tribulus terrestris (Zygophyllaceae); structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Reperfusion Injury 06/01/2010 - "Tribulosin protects myocardium against ischemia/reperfusion injury through PKCepsilon activation." 06/01/2010 - "Tribulosin protects rat hearts from ischemia/reperfusion injury." 06/01/2010 - "To investigate the protective effect of tribulosin, a monomer of the gross saponins from Tribulus terrestris, against cardiac ischemia/reperfusion injury and the underlying mechanism in rats. "
2.	Ischemia 06/01/2010 - "The hearts were assigned to seven groups: control, ischemia/reperfusion (I/R), treatment with gross saponins from Tribulus terrestris (GSTT) 100 mg/L, treatment with tribulosin (100, 10, and 1 nmol/L) and treatment with a PKC inhibitor (chelerythrine) (1 micromol/L). "
3.	Infarction (Infarctions) 06/01/2010 - "GSTT and various concentrations of tribulosin treatment decreased the infarct size to 24.33%, 20.24%, 23.19%, and 30.32% (P<0.01). "
4.	Hypoxia (Hypoxemia) 12/01/2011 - "Tribulosin suppresses apoptosis via PKC epsilon and ERK1/2 signaling pathway during hypoxia/reoxygenation in neonatal rat ventricular cardiac myocytes."